TABLE 7.
Association between RBP4 and other cytokines1
| Cytokine | Study design | Study population | Sex | Age,2 y | Study size, n | Cytokine measurement method | RBP4 measurement method | Analysis | Relation | RBP4 specimen | Authors, year (ref) |
| IL-8 | CC | Patients with dilated inflammatory cardiomyopathy | 48 M; 6 F | 41.84 ± 9.77 to 49.54 ± 13.97 | 54 | Multiplex ELISA (Biorad) | ELISA | Correlation | + | Plasma | Bobbert et al., 2009 (28) |
| IL-10 | CS | Nonobese, nondiabetic CKD patients undergoing MHD treatment | 29 M; 18 F | 44–80 | 15 | mRNA level | ELISA | Correlation | None | Plasma | Barazzoni et al., 2011 (72) |
| IL-18 | CS | Healthy obese subjects | F | 45 ± 9.3 | 63 | Solid-phase enzyme immunoassay | Nephelometry | NM | None | Serum | Broch et al., 2010 (74) |
| CD68 | Basement analysis of an intervention | Healthy obese subjects | NM | 24–62 | 16 | Gene expression | Gene expression | Correlation | + | Adipose biopsy | Yao-Borengasser et al., 2007 (53) |
1
CC, case-control; CKD, chronic kidney disease; CS, cross-sectional; F, female; M, male. MHD, maintenance hemodialysis; NM, not mentioned; RBP4, retinol binding protein 4; ref, reference; +, positive.
2
Values are ranges or means ± SDs.